Department Of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement Uniform Formulary Additional Discount Program

Background The Department Of Defense Dod Is Required By Law 10 U S C 1074G To Establish An Effective Efficient Integrated Pharmacy Benefits Program For The Military Health System Mhs Which Includes The Purchase Pharmaceutical Agents The Law And Implementing Regulation 32 Cfr Section 199 21 Describe The Process By Which The Dod Pharmacy And Therapeutics P Amp T Committee Will Consider The Relative Clinical Effectiveness And Relative Cost Effectiveness Of Pharmaceutical Agents In A Therapeutic Class In Recommending The Selection Of Agents For The Dod Uniform Formulary Uf And For Cost Sharing Purposes The Classification Of A Pharmaceutical Agent As Generic Formulary Basic Core Formulary Bcf Extended Core Formulary Ecf Or Non Formulary Nf Prior To The Scheduled P Amp T Committee Meeting A Request For Quotation Rfq For Pharmaceutical Agents Within Drug Classes Identified For Placement On The Uf Has Been Issued To Obtain Quotes From Industry The Defense Health Agency May Award Uniform Formulary Blanket Purchase Agreements Uf Bpa And The Uniform Formulary Additional Discount Program Agreements Uf Adp Based On The Uf Decision This Process Is Described In The Attached Rfq P Amp T Committee Meeting May 2021 The Following Newly Approved Agents And Drug Classes Subclass Will Be Reviewed Gemtesa Drug Class Overactive Bladder Sub Class Na Klisyri Drug Class Antineoplastic And Premalignant Lesion Agents Sub Class Na Lupkynis Drug Class Immunosuppressives Sub Class Na Reditrex Drug Class Antirheumatics Sub Class Injectable Methotrexate Thyquidity Drug Class Thyroid And Antithyroid Agents Sub Class Na Tyblume Drug Class Contraceptive Agents Sub Class Monophasics With 20 Mcg Estrogen Verquvo Drug Class Cardiovascular Agents Miscellaneous Sub Class Na Vesicare Drug Class Overactive Bladder Agents Sub Class Na The Rfq Including Uf Bpa And Uf Adp Appendices Are Attached Herein The Instructions Important Deadlines And Point Of Contacts Are In Document Rfq Ht9402 21 Q 0002 1 Pre Proposal Teleconference Is On February 10 2021 Details Are Stated In Part 2 5 Pre Proposal Teleconference Contact Rfq Point Of Contact Poc For Agenda And Dial In Information Responses To The Clinical Questions In Part 3 4 Shall Be Submitted Via E Mail To The Rfq Poc Stated In Part 2 3 No Later Than The Date Stated In Part 2 4

Refer document

FileName	File Description
Global Tender Document	Tender Notice